In order to assess the therapeutic effects of PFD, fibrosis-related factors IL-6 and COL1A1 levels in MLF supernatant induced by TGF-β1, as well as those in serum and BALF of mice with BLM-induced pulmonary fibrosis were estimated. This evidence concerns the gene TGFB1 and polyostotic fibrous dysplasia.